Free Trial

Aptose Biosciences (TSE:APS) Stock Passes Below 200-Day Moving Average - Here's Why

Aptose Biosciences logo with Medical background
Remove Ads

Aptose Biosciences Inc. (TSE:APS - Get Free Report) NASDAQ: APTO shares crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of C$10.66 and traded as low as C$4.98. Aptose Biosciences shares last traded at C$4.98, with a volume of 1,087 shares trading hands.

Analyst Ratings Changes

Separately, Alliance Global Partners upgraded Aptose Biosciences to a "strong-buy" rating in a research note on Thursday, February 27th.

Get Our Latest Report on Aptose Biosciences

Aptose Biosciences Trading Down 11.4 %

The stock has a market capitalization of C$207.11 million, a PE ratio of -0.96 and a beta of 1.36. The company has a debt-to-equity ratio of -117.37, a quick ratio of 5.41 and a current ratio of 1.05. The company has a 50 day moving average of C$6.61 and a two-hundred day moving average of C$10.52.

About Aptose Biosciences

(Get Free Report)

Aptose Biosciences Inc, a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies.

Read More

Should You Invest $1,000 in Aptose Biosciences Right Now?

Before you consider Aptose Biosciences, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aptose Biosciences wasn't on the list.

While Aptose Biosciences currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock

Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock

Is Marjorie Taylor Greene the next Nancy Pelosi when it comes to stock trading? After being appointed to the DOGE Committee, MTG made a significant Tesla stock purchase—raising questions about congres

Related Videos

7 Inflation-Proof Stocks to Protect Your Portfolio
7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads